{"id":9027,"date":"2024-01-09T14:16:00","date_gmt":"2024-01-09T14:16:00","guid":{"rendered":"https:\/\/dailyai.com\/?p=9027"},"modified":"2024-01-10T09:17:28","modified_gmt":"2024-01-10T09:17:28","slug":"nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo","status":"publish","type":"post","link":"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","title":{"rendered":"NVIDIA amplia l'offerta di modelli per la scoperta di farmaci attraverso BioNeMo"},"content":{"rendered":"<p><b>NVIDIA ha aggiunto nuovi modelli di intelligenza artificiale generativa a BioNeMo, un servizio cloud per la creazione e la distribuzione di modelli di intelligenza artificiale per la scoperta di farmaci.<\/b><\/p>\n<p><span style=\"font-weight: 400;\">BioNeMo \u00e8 una piattaforma di IA generativa progettata per supportare il processo di scoperta dei farmaci, per il quale l'IA ha mostrato un'enorme attitudine nel 2023. <\/span><span style=\"font-weight: 400;\">Ospita una serie di modelli di intelligenza artificiale e servizi cloud specificamente concepiti per lo sviluppo di farmaci.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Utilizzando l'intelligenza artificiale per modellare i componenti molecolari, BioNeMo consente ai ricercatori di generare nuove strutture molecolari che potrebbero portare a farmaci efficaci, riducendo la necessit\u00e0 di esperimenti fisici costosi e dispendiosi in termini di tempo.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Naturalmente, tutti questi modelli e servizi sono supportati dall'infrastruttura hardware NVIDIA AI leader di categoria.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">BioNeMo si affianca alla pi\u00f9 ampia <a href=\"https:\/\/www.nvidia.com\/en-gb\/clara\/\" target=\"_blank\" rel=\"noopener\">Piattaforma NVIDIA Clara<\/a>. NVIDIA Clara \u00e8 una piattaforma di elaborazione specifica per il settore sanitario, progettata per sfruttare la potenza dell'intelligenza artificiale e dell'elaborazione avanzata per affrontare le sfide del settore sanitario.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La piattaforma Clara \u00e8 fondamentale per la strategia di AI generativa dell'azienda nel settore sanitario - che NVIDIA dichiara essere in fase di realizzazione da oltre un decennio - e offre strumenti e framework specificamente ottimizzati per applicazioni di imaging medico, analisi genomica, scoperta di farmaci e altre aree correlate alla salute.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kimberly Powell, vicepresidente di NVIDIA per il settore sanitario, ha spiegato di BioNeMo: \"Il settore sanitario \u00e8 intrinsecamente complicato. Il nostro obiettivo \u00e8 quello di semplificare le cose per i ricercatori che possono mettere a punto questi modelli su dati proprietari, eseguire l'inferenza di modelli di intelligenza artificiale tramite browser Web o API cloud e accedere a modelli pre-addestrati per lo sviluppo di farmaci\".\u00a0<\/span><\/p>\n<h2>Una selezione di modelli biotecnologici e sanitari<\/h2>\n<p><span style=\"font-weight: 400;\">La suite di strumenti di BioNeMo \u00e8 impressionante, dal modello MolMIM di NVIDIA, abile nel generare piccole molecole, a Phenom-Beta di Recursion, un modello leader per l'incorporazione di immagini di microscopia cellulare.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Recursion \u00e8 la prima a offrire un modello di intelligenza artificiale attraverso le API cloud BioNeMo di NVIDIA. Phenom-Beta estrae le caratteristiche dalle immagini di microscopia cellulare, fornendo approfondimenti sulle funzioni cellulari e sulle reazioni delle cellule a farmaci o modifiche genetiche.<\/span><\/p>\n<figure id=\"attachment_9028\" aria-describedby=\"caption-attachment-9028\" style=\"width: 1024px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-9028 size-large\" src=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-1024x515.gif\" alt=\"NVIDIA AI\" width=\"1024\" height=\"515\" srcset=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-1024x515.gif 1024w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-300x151.gif 300w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-768x386.gif 768w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-370x186.gif 370w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-800x402.gif 800w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-740x372.gif 740w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-20x10.gif 20w, https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/vit_diff_mask_ratios-96x48.gif 96w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption id=\"caption-attachment-9028\" class=\"wp-caption-text\">Phenom-Beta supera i compiti di ricostruzione delle immagini, che valutano le prestazioni del modello. Fonte: <a href=\"https:\/\/blogs.nvidia.com\/blog\/drug-discovery-bionemo-generative-ai\/\" target=\"_blank\" rel=\"noopener\">NVIDIA<\/a>.<\/figcaption><\/figure>\n<p><a href=\"https:\/\/blogs.nvidia.com\/blog\/drug-discovery-bionemo-generative-ai\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Secondo NVIDIA<\/span><\/a><span style=\"font-weight: 400;\">, Recursion sta potenziando le proprie risorse di supercomputing aggiungendo oltre 500 GPU NVIDIA H100 al proprio sistema, quadruplicandone la potenza di calcolo. Sar\u00e0 uno dei supercomputer pi\u00f9 potenti del settore biofarmaceutico.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">La scoperta di farmaci \u00e8 emersa come uno dei principali punti di forza dell'IA generativa nel settore scientifico, con i modelli che aiutano a scoprire <\/span><a href=\"https:\/\/dailyai.com\/it\/2023\/06\/researchers-build-breakthrough-ai-model-for-drug-discovery\/\"><span style=\"font-weight: 400;\">nuove classi di antibiotici<\/span><\/a><span style=\"font-weight: 400;\">, identificando <\/span><a href=\"https:\/\/dailyai.com\/it\/2023\/07\/ai-accelerates-discovery-of-anti-aging-drugs-in-new-study\/\"><span style=\"font-weight: 400;\">composti in grado di rallentare l'invecchiamento<\/span><\/a><span style=\"font-weight: 400;\">, e <\/span><a href=\"https:\/\/dailyai.com\/it\/2023\/12\/astrazeneca-bets-247m-on-ai-company-developing-cancer-drug\/\"><span style=\"font-weight: 400;\">sviluppo di farmaci antitumorali<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Grazie alla sua capacit\u00e0 di elaborare grandi quantit\u00e0 di dati e di ricavarne nuove conoscenze, l'IA generativa sta mantenendo la promessa del suo nome di creare nuove strade per la ricerca medica e biotecnologica.<\/span><\/p>\n<p>Questo arriva mentre NVIDIA <a href=\"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-announces-new-chips-and-tools-for-on-device-ai\/\">annuncia nuove GPU e hardware<\/a> per l'elaborazione locale dell'intelligenza artificiale sul dispositivo.<\/p>","protected":false},"excerpt":{"rendered":"<p>NVIDIA ha aggiunto nuovi modelli di AI generativa a BioNeMo, un servizio cloud per la creazione e la distribuzione di modelli di AI per la scoperta di farmaci. BioNeMo \u00e8 una piattaforma di IA generativa progettata per supportare il processo di scoperta dei farmaci, per il quale l'IA ha mostrato una straordinaria attitudine nel 2023. Ospita una serie di modelli di IA e servizi cloud specificamente pensati per lo sviluppo di farmaci. Utilizzando l'intelligenza artificiale per modellare i componenti molecolari, BioNeMo consente ai ricercatori di generare nuove strutture molecolari che potrebbero portare a farmaci efficaci, riducendo la necessit\u00e0 di esperimenti fisici costosi e dispendiosi in termini di tempo.  Naturalmente, tutti questi modelli e servizi sono supportati dall'AI leader della categoria di NVIDIA.<\/p>","protected":false},"author":2,"featured_media":1059,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[203,260,204,101,106],"class_list":["post-9027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-biotech","tag-drug-discovery","tag-healthcare","tag-medtech","tag-nvidia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI<\/title>\n<meta name=\"description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\" \/>\n<meta property=\"og:description\" content=\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-09T14:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-10T09:17:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sam Jeans\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sam Jeans\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"author\":{\"name\":\"Sam Jeans\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\"},\"headline\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"keywords\":[\"Biotech\",\"Drug discovery\",\"Healthcare\",\"MedTech\",\"Nvidia\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\",\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"datePublished\":\"2024-01-09T14:16:00+00:00\",\"dateModified\":\"2024-01-10T09:17:28+00:00\",\"description\":\"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/shutterstock_1606529806.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Nvidia AI products\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA expands offerings of drug discovery models through BioNeMo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/711e81f945549438e8bbc579efdeb3c9\",\"name\":\"Sam Jeans\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g\",\"caption\":\"Sam Jeans\"},\"description\":\"Sam is a science and technology writer who has worked in various AI startups. When he\u2019s not writing, he can be found reading medical journals or digging through boxes of vinyl records.\",\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/in\\\/sam-jeans-6746b9142\\\/\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/it\\\/author\\\/samjeans\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NVIDIA amplia l'offerta di modelli per la scoperta di farmaci attraverso BioNeMo | DailyAI","description":"NVIDIA ha aggiunto nuovi modelli di intelligenza artificiale generativa a BioNeMo, un servizio cloud per la creazione e la distribuzione di modelli di intelligenza artificiale per la scoperta di farmaci.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_locale":"it_IT","og_type":"article","og_title":"NVIDIA expands offerings of drug discovery models through BioNeMo | DailyAI","og_description":"NVIDIA added new generative AI models to BioNeMo, a cloud service for creating and deploying AI models for drug discovery.","og_url":"https:\/\/dailyai.com\/it\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","og_site_name":"DailyAI","article_published_time":"2024-01-09T14:16:00+00:00","article_modified_time":"2024-01-10T09:17:28+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","type":"image\/jpeg"}],"author":"Sam Jeans","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Scritto da":"Sam Jeans","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"author":{"name":"Sam Jeans","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9"},"headline":"NVIDIA expands offerings of drug discovery models through BioNeMo","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"},"wordCount":442,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","keywords":["Biotech","Drug discovery","Healthcare","MedTech","Nvidia"],"articleSection":["Product"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","url":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/","name":"NVIDIA amplia l'offerta di modelli per la scoperta di farmaci attraverso BioNeMo | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","datePublished":"2024-01-09T14:16:00+00:00","dateModified":"2024-01-10T09:17:28+00:00","description":"NVIDIA ha aggiunto nuovi modelli di intelligenza artificiale generativa a BioNeMo, un servizio cloud per la creazione e la distribuzione di modelli di intelligenza artificiale per la scoperta di farmaci.","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/05\/shutterstock_1606529806.jpg","width":1000,"height":667,"caption":"Nvidia AI products"},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/nvidia-expands-its-offerings-of-drug-discovery-models-through-bionemo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA expands offerings of drug discovery models through BioNeMo"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"La vostra dose quotidiana di notizie sull'intelligenza artificiale","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/711e81f945549438e8bbc579efdeb3c9","name":"Sam Jeans","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a24a4a8f8e2a1a275b7491dc9c9f032c401eabf23c3206da4628dc84b6dac5c8?s=96&d=robohash&r=g","caption":"Sam Jeans"},"description":"Sam \u00e8 uno scrittore di scienza e tecnologia che ha lavorato in diverse startup di intelligenza artificiale. Quando non scrive, lo si pu\u00f2 trovare a leggere riviste mediche o a scavare tra scatole di dischi in vinile.","sameAs":["https:\/\/www.linkedin.com\/in\/sam-jeans-6746b9142\/"],"url":"https:\/\/dailyai.com\/it\/author\/samjeans\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/comments?post=9027"}],"version-history":[{"count":9,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9027\/revisions"}],"predecessor-version":[{"id":9063,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/posts\/9027\/revisions\/9063"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/media\/1059"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/media?parent=9027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/categories?post=9027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/it\/wp-json\/wp\/v2\/tags?post=9027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}